Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 6 | 2024 | 113 | 1.210 |
Why?
|
| Biological Products | 6 | 2024 | 94 | 1.030 |
Why?
|
| Vitamin D Deficiency | 2 | 2017 | 50 | 0.640 |
Why?
|
| Ustekinumab | 4 | 2024 | 5 | 0.580 |
Why?
|
| Adalimumab | 4 | 2024 | 36 | 0.580 |
Why?
|
| Infliximab | 4 | 2024 | 55 | 0.570 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2017 | 13 | 0.550 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2024 | 225 | 0.500 |
Why?
|
| Vitamin D | 1 | 2017 | 150 | 0.490 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2024 | 106 | 0.470 |
Why?
|
| Colitis, Ulcerative | 3 | 2024 | 84 | 0.460 |
Why?
|
| Gastrointestinal Agents | 4 | 2024 | 30 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2024 | 210 | 0.200 |
Why?
|
| Retrospective Studies | 6 | 2024 | 6136 | 0.180 |
Why?
|
| Graves Disease | 1 | 2017 | 16 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2017 | 17 | 0.140 |
Why?
|
| Hospitalization | 1 | 2024 | 1304 | 0.140 |
Why?
|
| Migraine Disorders | 1 | 2017 | 48 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2017 | 50 | 0.130 |
Why?
|
| Child | 4 | 2023 | 4333 | 0.130 |
Why?
|
| Linear Models | 1 | 2017 | 423 | 0.130 |
Why?
|
| Young Adult | 3 | 2024 | 4395 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 381 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 928 | 0.120 |
Why?
|
| Lactose Intolerance | 1 | 2013 | 5 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1066 | 0.110 |
Why?
|
| Anxiety | 1 | 2017 | 400 | 0.110 |
Why?
|
| Body Height | 1 | 2013 | 75 | 0.110 |
Why?
|
| Diabetes Insipidus | 1 | 2013 | 3 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2024 | 5264 | 0.110 |
Why?
|
| Proprotein Convertase 1 | 1 | 2013 | 8 | 0.110 |
Why?
|
| Proprotein Convertases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 10 | 0.110 |
Why?
|
| Adolescent | 3 | 2023 | 5958 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2017 | 892 | 0.100 |
Why?
|
| Adult | 6 | 2024 | 15982 | 0.100 |
Why?
|
| Male | 7 | 2024 | 27969 | 0.100 |
Why?
|
| Humans | 12 | 2024 | 60133 | 0.100 |
Why?
|
| Female | 7 | 2024 | 31235 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 96 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2010 | 46 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 867 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2010 | 102 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 487 | 0.080 |
Why?
|
| Middle Aged | 4 | 2024 | 16545 | 0.070 |
Why?
|
| Obesity | 1 | 2013 | 1191 | 0.060 |
Why?
|
| Drug Substitution | 1 | 2024 | 42 | 0.060 |
Why?
|
| Biological Factors | 1 | 2023 | 23 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2013 | 1850 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 679 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 805 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 263 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 584 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 744 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2477 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 424 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 13 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 7 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 629 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 18 | 0.040 |
Why?
|
| Menstruation Disturbances | 1 | 2017 | 19 | 0.040 |
Why?
|
| Thyroxine | 1 | 2017 | 53 | 0.030 |
Why?
|
| Calcifediol | 1 | 2013 | 4 | 0.030 |
Why?
|
| Puberty | 1 | 2013 | 57 | 0.030 |
Why?
|
| Osmoregulation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Heterozygote | 1 | 2013 | 166 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 174 | 0.030 |
Why?
|
| Alleles | 1 | 2013 | 423 | 0.020 |
Why?
|
| United States | 1 | 2024 | 7609 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 457 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 1158 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1532 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 2501 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 2474 | 0.010 |
Why?
|